Population-based BRCA1/BRCA2 screening in Ashkenazi Jews: A call for evidence

Genetics in Medicine

Volumn 11, Issue 9, 2009, Pages 620-621

  Levy Lahad, Ephrat ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

BREAST CANCER; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; GENE MUTATION; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HEMOCHROMATOSIS; HOMOZYGOSITY; HUMAN; NOTE; OVARY CANCER; PHLEBOTOMY; POPULATION BASED CASE CONTROL STUDY;

BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; JEWS; OVARIAN NEOPLASMS; POPULATION;

EID: 70349665342     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e3181b765d3     Document Type: Note

References (10)

1. Rubinstein W, Jiang H, Dellefave L, Rademaker AW. Cost-effectiveness of population-based BRCA1/2 testing and ovarian cancer prevention for Ashkenazi Jews: a call for dialogue. Genet Med 2009;11:629-639.
2. Khoury MJ, McCabe LL, McCabe ER. Population screening in the age of genomic medicine. N Engl J Med 2003;348:1604-1605.
3. Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, Bradley L. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med 2007;9:665-674.
4. Khoury MJ, Berg A, Coates R, Evans J, Teutsch SM, Bradley LA. The evidence dilemma in genomic medicine. Health Aff (Millwood) 2008;27: 1600-1611.
5. U.S. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med 2005;143:355-361.
6. Begg CB. On the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst 2002;94:1221-1226.
7. Grosse SD, Rogowski WH, Ross LF, Cornel MC, Dondorp WJ, Khoury MJ. Population screening for genetic disorders in the 21st century: evidence, economics, and ethics [published online ahead of print June 29, 2009]. Public Health Genomics.
8. Calzone KA, Prindiville SA, Jourkiv O, et al. Randomized comparison of group versus individual genetic education and counseling for familial breast and/or ovarian cancer. J Clin Oncol 2005;23:3455-3464.
9. Cohen JT, Neumann PJ, Weinstein MC. Does preventive care save money? Health economics and the presidential candidates. N Engl J Med 2008;358: 661-663.
10. Beutler E. Carrier screening for Gaucher disease: more harm than good? JAMA 2007;298:1329 -1331.